Search Results - "Liguori, Nora Fernández"
-
1
SARS-CoV-2 RNA detection in cerebrospinal fluid: Presentation of two cases and review of literature
Published in Brain, behavior, & immunity. Health (01-08-2021)“…Neurological manifestations of SARS-CoV-2 infection are multiple and heterogeneous. However, confirmation of nervous system impairment by viral RNA detection…”
Get full text
Journal Article -
2
Clinical impact of gender and age at onset on disease trajectory in primary progressive multiple sclerosis patients
Published in Multiple sclerosis (01-03-2024)“…Background and Objectives: Primary-progressive multiple sclerosis (PPMS) is characterized by gradual neurological deterioration without relapses. This study…”
Get full text
Journal Article -
3
Acute disseminated encephalomyelitis following vaccination against SARS-CoV-2: A case report
Published in Brain, behavior, & immunity. Health (01-03-2022)“…Acute disseminated encephalomyelitis (ADEM) is an inflammatory emyelinating disease of the central nervous system that is usually considered a monophasic…”
Get full text
Journal Article -
4
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodies
Published in Multiple sclerosis journal - experimental, translational and clinical (01-01-2023)“…Background We aimed to determine the proportion of highly active multiple sclerosis patients under high-efficacy therapies (HETs) achieve no evidence of…”
Get full text
Journal Article -
5
Marchiafava–Bignami Disease Associated with Spinal Involvement
Published in Case reports in neurological medicine (28-10-2020)“…Marchiafava–Bignami disease (MBD) is a rare disorder of unknown etiology, strongly associated with alcoholism and malnutrition. MBD causes primary involvement…”
Get full text
Journal Article -
6
Family planning in Argentinian women with multiple sclerosis: An important yet seldom approached issue
Published in Multiple sclerosis journal - experimental, translational and clinical (01-04-2021)“…Background The purpose of this study was to assess family planning (FP) among women with multiple sclerosis (WwMS). Methods We invited 604 WwMS to answer a…”
Get full text
Journal Article -
7
Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study
Published in Journal of the neurological sciences (15-07-2024)“…We aimed to assess the treatment strategies utilized in patients with neuromyelitis optica spectrum disorder (NMOSD) experiencing relapses, including their…”
Get full text
Journal Article -
8
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina
Published in Clinical neuropharmacology (01-07-2024)“…The aim was to evaluate patient profiles, effectiveness and safety of cladribine (CLAD) in patients with relapsing-remitting multiple sclerosis in Argentina…”
Get full text
Journal Article -
9
Argentinean consensus recommendations for the use of telemedicine in clinical practice in adult people with multiple sclerosis
Published in Neurological sciences (01-02-2023)“…Background The use of telemedicine has quickly increased during of the COVID-19 pandemic. Given that unmet needs and barriers to multiple sclerosis (MS) care…”
Get full text
Journal Article -
10
Accumulative risk of clinical event in high-risk radiologically isolated syndrome in Argentina: data from the nationwide registry RelevarEM
Published in Journal of neurology (01-04-2022)“…Introduction We aimed to analyze the accumulative risk of MRI and OB factors for evolution from RIS to MS in subjects included in the Argentinean MS registry…”
Get full text
Journal Article -
11
Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina
Published in Neurological sciences (2023)“…The objective was to evaluate time to reach an EDSS of 4, 6, and 7 in NMOSD and MOGAD patients included in the Argentinean MS and NMOSD registry (RelevarEM,…”
Get full text
Journal Article -
12
Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM)
Published in Neurological sciences (01-06-2020)“…The objective of this study was to describe and compare the baseline epidemiological data of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder…”
Get full text
Journal Article -
13
Platelet-to-lymphocyte ratio differs between MS and NMOSD at disease onset and predict disability
Published in Multiple sclerosis and related disorders (01-02-2022)“…•PLR and NLR have been assessed in several autoimmune diseases as biomarkers of inflammation.•PLR is increased in NMOSD when compared to MS, but no significant…”
Get full text
Journal Article -
14
Consensus recommendations for the diagnosis and treatment of primary progressive multiple sclerosis in Latin America
Published in Journal of the neurological sciences (15-10-2018)“…Despite the availability of a large amount of information regarding the management and care of relapsing remitting multiple sclerosis (RRMS) patients, there is…”
Get full text
Journal Article -
15
Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM)
Published in Multiple sclerosis and related disorders (01-09-2024)“…•We studied 139 NMOSD patients from Argentina on AZA (n = 105), MMF (n = 5), or RTX (n = 29).•The annualized relapse rate decreased post-treatment in 51.1 %,…”
Get full text
Journal Article -
16
Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM)
Published in Neurological sciences (01-11-2020)“…Background Primary progressive multiple sclerosis (PPMS) is an infrequent clinical form of multiple sclerosis (MS). Scarce information is available about PPMS…”
Get full text
Journal Article -
17
Rebound activity after fingolimod cessation: A case – control study
Published in Multiple sclerosis and related disorders (01-01-2022)“…•The median time to rebound activity after fingolimod discontinuation was 50 days (IQR 37.25 – 86.75).•The main reason for stopping fingolimod in this cohort…”
Get full text
Journal Article -
18
Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry
Published in Multiple sclerosis journal - experimental, translational and clinical (01-10-2023)“…We aimed to evaluate mortality and causes of death among Argentinean neuromyelitis optica spectrum disorder (NMOSD) patients and identify predictors of death…”
Get full text
Journal Article -
19
Clinical and demographic characteristics of male MS patients included in the national registry-RelevarEM. Does sex or phenotype make the difference in the association with poor prognosis?
Published in Multiple sclerosis and related disorders (01-02-2022)“…•Data in cohort MS studies is seldom disaggregated by sex and males are poorly considered.•Results in MS studies may be markedly biased by the female…”
Get full text
Journal Article -
20
Seasonal variation in attacks of neuromyelitis optica spectrum disorders and multiple sclerosis: Evaluation of 794 attacks from a nationwide registry in Argentina
Published in Multiple sclerosis and related disorders (01-02-2022)“…•Seasonal variation has been reported in autoimmune diseases of the CNS, like MS.•We aimed to analyze the seasonality of NMOSD and MS attacks in…”
Get full text
Journal Article